These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 7029774

  • 1. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF.
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [Abstract] [Full Text] [Related]

  • 2. Effects of phenobarbital and beta-naphthoflavone on the activation of cyclophosphamide to mutagenic metabolites in vitro by liver and kidney from male and female rats.
    Hales BF, Jain R.
    Biochem Pharmacol; 1980 Jul 15; 29(14):2031-7. PubMed ID: 6996685
    [No Abstract] [Full Text] [Related]

  • 3. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
    Veres Z, Török G, Tóth E, Vereczkey L, Jemnitz K.
    Mutat Res; 2005 Sep 05; 586(1):18-27. PubMed ID: 16006184
    [Abstract] [Full Text] [Related]

  • 4. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
    Della Morte R, Belisario MA, Farina C, Martire G, Staiano N, De Lorenzo F.
    Boll Soc Ital Biol Sper; 1982 Aug 30; 58(16):1061-7. PubMed ID: 7138675
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver.
    Ong T, Mukhtar M, Wolf CR, Zeiger E.
    J Environ Pathol Toxicol; 1980 Aug 30; 4(1):55-65. PubMed ID: 7441130
    [Abstract] [Full Text] [Related]

  • 6. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
    Johnson TE, Umbenhauer DR, Galloway SM.
    Environ Mol Mutagen; 1996 Aug 30; 28(1):51-9. PubMed ID: 8698047
    [Abstract] [Full Text] [Related]

  • 7. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
    Reddy TV, Ramanathan R, Benjamin T, Grantham PH, Weisburger EK.
    J Natl Cancer Inst; 1986 Feb 30; 76(2):291-7. PubMed ID: 3456067
    [Abstract] [Full Text] [Related]

  • 8. Activation of carcinogens and mutagens by rat colon mucosa.
    Fang WF, Strobel HW.
    Cancer Res; 1978 Sep 30; 38(9):2939-44. PubMed ID: 354782
    [Abstract] [Full Text] [Related]

  • 9. Influence of ethanol and benzene on cytochrome P-450 fractions in rat liver microsomes.
    Beaune P, Flinois JP, Le Provost E, Leroux JP.
    Drug Metab Dispos; 1983 Sep 30; 11(5):499-506. PubMed ID: 6138238
    [Abstract] [Full Text] [Related]

  • 10. Effect of nifedipine on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone.
    Koleva M, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1991 Sep 30; 17(2-3):122-8. PubMed ID: 1819909
    [Abstract] [Full Text] [Related]

  • 11. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
    Salhab AS, James MO, Wang SL, Shiverick KT.
    Drug Metab Dispos; 1986 Sep 30; 14(4):471-6. PubMed ID: 2873995
    [Abstract] [Full Text] [Related]

  • 12. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC, Hilliard JB, Wong DD, Chambers MA, Park SS, Gelboin HV, Gerber N.
    J Pharmacol Exp Ther; 1990 Aug 30; 254(2):720-31. PubMed ID: 2117068
    [Abstract] [Full Text] [Related]

  • 13. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
    Kedderis GL, Rickert DE.
    Drug Metab Dispos; 1985 Aug 30; 13(1):58-61. PubMed ID: 2858378
    [Abstract] [Full Text] [Related]

  • 14. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH, Bennett GD, Slattery JT, Amore BM, Bajpai M, Levy RH.
    Teratology; 1995 Dec 30; 52(6):324-32. PubMed ID: 8711619
    [Abstract] [Full Text] [Related]

  • 15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 30; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gut.
    Carrière V, de Waziers I, Courtois YA, Leroux JP, Beaune PH.
    Mutat Res; 1992 Jul 30; 268(1):11-20. PubMed ID: 1378177
    [Abstract] [Full Text] [Related]

  • 17. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
    Small DS, McNamara PJ.
    Drug Metab Dispos; 1995 Apr 30; 23(4):465-72. PubMed ID: 7600913
    [Abstract] [Full Text] [Related]

  • 18. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM, Franklin MR.
    Mol Pharmacol; 1982 Mar 30; 21(2):527-32. PubMed ID: 7099151
    [Abstract] [Full Text] [Related]

  • 19. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
    Mori Y, Konishi Y.
    IARC Sci Publ; 1991 Mar 30; (105):398-403. PubMed ID: 1855888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.